We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Gallaway

Michael Gallaway OD

Associate professor of optometry at the Pennsylvania College of Optometry (PCO) at Salus University in Philadelphia. He is also in private practice in Marlton, NJ specializing in pediatric optometry and vision therapy.

Dr. Michael Gallaway is an associate professor of optometry at the Pennsylvania College of Optometry (PCO) at Salus University in Philadelphia. He is also in private practice in Marlton, NJ specializing in pediatric optometry and vision therapy. His research interests include the efficacy of vision therapy, the impact of concussions on visual function, amblyopia, the impact of vision disorders on reading and learning, and school vision screening protocols. He was the Principal Investigator at PCO for the Convergence Insufficiency Treatment Trial, and is the Principal Investigator at PCO for the ongoing CITT Attention and Reading Trial (CITT-ART). He is also a Clinical Investigator with PEDIG and has participated in most of the Amblyopia Treatment Studies.  He is a Fellow of The College of Optometrists in Vision Development (COVD) and the American Academy of Optometry (FAAO).